Long-term weight gain after initiating combination antiretroviral therapy in treatment-naïve Asian people living with human immunodeficiency virus
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 110, 21-28
Abstract
No abstract availableKeywords
Funding Information
- National Center for Global Health and Medicine (19 A1002)
This publication has 22 references indexed in Scilit:
- Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV AntiretroviralsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2018
- Weight Gain: A Possible Side Effect of All AntiretroviralsOpen Forum Infectious Diseases, 2017
- The HIV care cascade: Japanese perspectivesPLOS ONE, 2017
- Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and CanadaAIDS Research and Human Retroviruses, 2016
- Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune ActivationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2015
- Should the dose of tenofovir be reduced to 200–250 mg/day, when combined with protease inhibitors?Journal of the International AIDS Society, 2014
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and CanadaPLOS ONE, 2013
- Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatmentAIDS, 2012
- HIV infection and the risk of diabetes mellitusAIDS, 2009